Drug
Ckd 339
Ckd 339: highest development phase Phase 1, developed by Chong Kun Dang Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chong Kun Dang Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| CKD-339 NCT07748702 | Phase 1 | Hypertension |
Latest
No recent events.
Follow Ckd 339 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.